Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Akzo describes selective 5-HT2C agonists for depression and other CNS disorders

Oct. 8, 1998

Gruenenthal develops new opioid analgesics

Oct. 8, 1998

Melatonin neuroprotective in a mouse TBI model

Oct. 7, 1998

rPAF-AH shows neuroprotective activity in hippocampal neurons

Oct. 7, 1998

Wakamoto discovers natural substances for Alzheimer's disease

Oct. 7, 1998

Dopamine reuptake inhibitors synthesized at Pola, useful for Parkinson's disease

Oct. 6, 1998

Canadian research team uncovers genetic basis of epileptic disorder

Oct. 6, 1998

Italian marketing approval obtained for metoclopramide nasal spray

Oct. 5, 1998

Study suggests beneficial effects of COX-2 inhibition in cerebral ischemia

Oct. 5, 1998

BASF describes novel inhibitors of cysteine proteases

Oct. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...